A Study of LY2216684 in Participants With Impaired Hepatic Function

NCT01241435 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: LY2216684

Sponsor

Eli Lilly and Company